SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 40 filers reported holding SINOVAC BIOTECH LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,000 | -25.0% | 500 | -18.2% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 611 | +22.2% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 500 | +400.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 100 | -80.0% | 0.00% | – |
| Q4 2014 | $3,000 | -40.0% | 500 | -50.0% | 0.00% | – |
| Q3 2014 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | -66.7% | 1,000 | -77.8% | 0.00% | – |
| Q2 2013 | $18,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |